ActRIIB-IN-3
ActRIIB-IN-3 is a ActRIIB inhibitor. ActRIIB-IN-3 inhibits the ActRIIB protein in the MSTN pathway and induces the reversal of skeletal muscle atrophy associated with cancer cachexia. ActRIIB-IN-3 is applicable for the research of cancer cachexia.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3039974-35-8
- Formule: C22H24N6
- Masse moléculaire:372.47
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
Chemical Information
-
CAS No. 3039974-35-8
-
Masse moléculaire 372.47
-
Formule C22H24N6
-
SMILES
CN1N=CC=C1C2=CNC3=NC=C(C4=CC=C(N5CCN(CC5)C)C=C4)C=C32
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)